Business
Stock Market Watch: Walmart and Merck in Focus
Analysts are divided on Merck after its cancer vaccine breakthrough, while Walmart is selling off on disappointing earnings. Jim Cramer highlights key market indicators.
Coverage timeline — 1 article
CNBC
Walmart is selling off on disappointing earnings, and analysts are divided on Merck after its cancer vaccine breakthrough.
2026-08-20 13:06 UTC